KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Retained Earnings (2018 - 2025)

Elanco Animal Health (ELAN) has disclosed Retained Earnings for 8 consecutive years, with -$2.2 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 11.9% to -$2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.2 billion through Dec 2025, down 11.9% year-over-year, with the annual reading at -$2.2 billion for FY2025, 11.9% down from the prior year.
  • Retained Earnings hit -$2.2 billion in Q4 2025 for Elanco Animal Health, down from -$199.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $65.0 million in Q2 2021 to a low of -$2.3 billion in Q4 2023.
  • Historically, Retained Earnings has averaged -$768.4 million across 5 years, with a median of -$540.0 million in 2021.
  • Biggest YoY gain for Retained Earnings was 130.26% in 2021; the steepest drop was 1691.72% in 2021.
  • Year by year, Retained Earnings stood at -$979.0 million in 2021, then surged by 59.96% to -$392.0 million in 2022, then crashed by 483.67% to -$2.3 billion in 2023, then rose by 14.77% to -$2.0 billion in 2024, then decreased by 11.9% to -$2.2 billion in 2025.
  • Business Quant data shows Retained Earnings for ELAN at -$2.2 billion in Q4 2025, -$199.0 million in Q3 2025, and -$192.0 million in Q2 2025.